1.29 (0.54%) 1d
Lost some gleam. Related to healthcare sector as a whole. Still confident in it. This is why you have a portfolio -- when some stocks fall, you have others to do the heavy lifting.

Unlock the latest expert's opinion. Its free

Create a FREE account to see the latest opinions & get alerts about when to buy, sell or hold stocks

Unlock the latest opinion & get signals
There have been few IPOs, but little biotech money has flowed into the market. This pressures CRL.
Sensational, but it's a high-growth stock at a high price. It's profitable.
(A Top Pick May 30/19, Up 44%) A contract research organization who partners with major pharma companies for drug testing and clinical testing. This is the second company in this space that has done well for them. He would stick with it.
It has had a great run and they consistently beat earnings expectations. He would be modestly concerned about their value metrics -- you are paying up right now. It has a 40 times PE ratio. He would wait until earnings are released.
They are a contractor to pharma labs. A lot of large pharma companies outsource to them. They have predictable margins. They are growing organically and through acquisition. (Analysts’ price target is $148.13)

Does safety testing, the efficacy, phase 1 through 3 trials for particular drugs for pharmaceutical companies. High growth, growing earnings last year at 17%.

Showing 1 to 7 of 7 entries
  • «
  • 1
  • »

Charles River Labs Intl(CRL-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 3

Stockchase rating for Charles River Labs Intl is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Charles River Labs Intl(CRL-N) Frequently Asked Questions

What is Charles River Labs Intl stock symbol?

Charles River Labs Intl is a American stock, trading under the symbol CRL-N on the New York Stock Exchange (CRL). It is usually referred to as NYSE:CRL or CRL-N

Is Charles River Labs Intl a buy or a sell?

In the last year, 3 stock analysts published opinions about CRL-N. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Charles River Labs Intl.

Is Charles River Labs Intl a good investment or a top pick?

Charles River Labs Intl was recommended as a Top Pick by on . Read the latest stock experts ratings for Charles River Labs Intl.

Why is Charles River Labs Intl stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Charles River Labs Intl worth watching?

3 stock analysts on Stockchase covered Charles River Labs Intl In the last year. It is a trending stock that is worth watching.

What is Charles River Labs Intl stock price?

On 2022-11-22, Charles River Labs Intl (CRL-N) stock closed at a price of $242.13.